AutoGenomics CYP 2C19 Test Used in Study to Personalize Clopidogrel (Plavix) Dosing in Patients

...onalizing treatment. In a recent study we used the autogenomics 2C19 test to screen for polymorphisms associated w...n Clopidogrel dosing to ensure patient safety. The autogenomics platform enables the rapid testing of such CYP 450...sure drug efficacy and patient safety". About autogenomics ...

AutoGenomics, Inc. Files Registration Statement for Initial Public Offering

...olicitation or sale would be unlawful prior to their registration or qualification under the securities laws of any such state. About AutoGenomics autogenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platform that can be...

AutoGenomics INFINITI Analyzer Receives Artistic Design Award

...nual Thermoforming Division Meeting selected the INFINITI(TM) Analyzer from autogenomics as a recipient of the artistic Multi-Part design award. The award given was...NA and Protein analysis into a self-contained unit." About AutoGenomics autogenomics Inc., a privately held company based in Carlsbad, CA, has developed the fir...

AutoGenomics Receives a Key European Patent for HPV Detection

...g we are excited that we can offer an automated solution that can significantly enhance workflow efficiency in the laboratory". About AutoGenomics autogenomics Inc., a privately held company based in Carlsbad, CA., has developed the first automated, microarray based multiplexing diagnostic platform that can b...

AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay

...to expand our product portfolio with additional warfarin assays and are committed to be the lead player in this testing arena." About AutoGenomics autogenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platforms that can b...

AutoGenomics Addresses TB Crisis With a Genetic Drug Resistance Test

...Della-Latta, Professor of Pathology at Columbia University Medical Center. She is also the Director of the Clinical Microbiology Laboratory, where the autogenomics test is currently being validated. ...

AutoGenomics in Medical Technology

Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity

CARLSBAD, Calif., Aug. 17 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that its CYP450 2C9-VKORC1 panel that it submitted to the FDA for 510(k) clearance late last year, has now been evaluated by the Harvard Medical School-Partners...

Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity

CARLSBAD, Calif., Aug. 17 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that its CYP450 2C9-VKORC1 panel that it submitted to the FDA for 510(k) clearance late last year, has now been evaluated by the Harvard Medical School-Partners...

AutoGenomics in Biological Technology

AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1

...versity were part of an effort from the Canadian Institute of Health Research to promote research in this area of important societal need. About autogenomics AutoGenomics, Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic plat...

AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference

...c and private companies over four days of simultaneous sessions. About autogenomics autogenomics Inc., a privately held company based in Carlsbad, CA, has developed an auto...

Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

...he lucrative market is further intensifying market competition. Key players profiled in report include Abbott Molecular Inc., Applied Biosystems Inc., autogenomics Inc., BioRad Laboratories, Celera Group, Clinical Data, Inc., Genzyme Genetics, Orchid Cellmark, Inc., PerkinElmer Inc., Quest Diagnostics Inc., Roche...

AutoGenomics to Present at Cowen Health Care Conference on March 17, 2008

...tomated molecular testing platform and diverse genetic applications on Monday 17th March 2008 at 11.30 AM Eastern Standard Time About AutoGenomics autogenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platforms that can b...

AutoGenomics Invited to Present at the JPMorgan Healthcare Conference

... CARLSBAD, Calif., Jan. 4 /PRNewswire/ -- autogenomics announced today that the Company has been invited and has accepted to prese...e companies over four days of simultaneous sessions. About AutoGenomics autogenomics Inc., a privately held company based in Carlsbad, CA, has developed the fir...